Rheumatoid Arthritis Clinical Trials in San Antonio

Showing 1881-1900 of 2,746 trials

Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients

NCT01871909

Lower body negative pressure (LBNP) is a laboratory model used to study hemorrhage in humans. The investigators hypothesize that the physiologic changes that occur with application of LBNP mimic those observed in bleeding and hemodynamically unstable trauma patients, and that LBNP is a truly valid model of human hemorrhage.

Physical Trauma

University of Colorado, Denver50 participantsStarted Oct 2013

Aurora, Colorado, United States • Denver, Colorado, United States • San Antonio, Texas, United States

COMPLETED< 1 mile

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

NCT00690469

This laboratory study is looking at genetic mutations and environmental exposure in young patients with retinoblastoma and in their parents and young healthy unrelated volunteers. Gathering information about gene mutations and environmental exposure may help doctors learn more about the causes of retinoblastoma in young patients.

Extraocular RetinoblastomaIntraocular RetinoblastomaRecurrent Retinoblastoma

Children's Oncology Group234 participantsStarted Jun 2008

Los Angeles, California, United States • Madera, California, United States • San Francisco, California, United States +49 more locations

Validation of Lower Body Negative Pressure (LBNP) Model of Human Hemorrhage in Trauma Patients

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Rheumatoid Arthritis Trials in Other Cities

A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel

An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Soft Contacts Observation of Risk and Education (SCORE)

Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Other Conditions in San Antonio